Vol 8, No 3 (June 2017): Journal of Gastrointestinal Oncology (Novel Biologics In Era of Precision Medicine)

Review Article

Molecular landscape and sub-classification of gastrointestinal cancers: a review of literature
Bita Fakhri, Kian-Huat Lim
Personalized and precision medicine: integrating genomics into treatment decisions in gastrointestinal malignancies
Trang H. Au, Kai Wang, David Stenehjem, Ignacio Garrido-Laguna
Predictive and prognostic biomarkers in personalized gastrointestinal cancer treatment
Helena Verdaguer, Tamara Saurí, Teresa Macarulla
Biologic therapy in esophageal and gastric malignancies: current therapies and future directions
Pamela Samson, A. Craig Lockhart
Current biologics for treatment of biliary tract cancers
Diana Y. Zhao, Kian-Huat Lim
Shifting paradigm of developing biologics for the treatment of pancreatic adenocarcinoma
Ying Zeng, Agnieszka A. Rucki, Xu Che, Lei Zheng
Biologics in bowel cancer
Marcus S. Noel
Biologics in gastrointestinal and pancreatic neuroendocrine tumors
Iris H. Liu, Pamela L. Kunz
Gastrointestinal stromal tumors (GISTs): point mutations matter in management, a review
Peter J. Oppelt, Angela C. Hirbe, Brian A. Van Tine
Immunotherapy in gastrointestinal cancers
Patrick Grierson, Kian-Huat Lim, Manik Amin
Biological agents in gastrointestinal cancers: adverse effects and their management
Nivedita Arora, Arjun Gupta, Preet Paul Singh
Primary and acquired resistance to biologic therapies in gastrointestinal cancers
Sam J. Lubner, Nataliya V. Uboha, Dustin A. Deming
Cost-effectiveness of precision medicine in gastrointestinal stromal tumor and gastric adenocarcinoma
Simon B. Zeichner, Daniel A. Goldstein, Christine Kohn, Christopher R. Flowers
Promising therapeutics of gastrointestinal cancers in clinical trials
Lingling Du, Zheng Che, Andrea Wang-Gillam

Original Article

Bone marrow tolerance during postoperative chemotherapy in colorectal carcinomas
Neil B. Newman, Rebecca A. Moss, Nell Maloney-Patel, Kristen Donohue, Teresa V. Brown, Michael J. Nissenblatt, Shou-En Lu, Salma K. Jabbour
Gemcitabine/nab-paclitaxel as second-line therapy following FOLFIRINOX in metastatic/advanced pancreatic cancer—retrospective analysis of response
Khanh T. Nguyen, Aparna Kalyan, H. Scott Beasley, Aatur D. Singhi, Weijing Sun, Herbert J. Zeh, Daniel Normolle, Nathan Bahary
Comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine with nab-paclitaxel in unresectable pancreatic cancer
Tetsuhito Muranaka, Masaki Kuwatani, Yoshito Komatsu, Kentaro Sawada, Hiroshi Nakatsumi, Yasuyuki Kawamoto, Satoshi Yuki, Yoshimasa Kubota, Kimitoshi Kubo, Shuhei Kawahata, Kazumichi Kawakubo, Hiroshi Kawakami, Naoya Sakamoto
Overall and disease-free survival in patients treated with CRS + HIPEC with cisplatin and paclitaxel for gastric cancer with peritoneal carcinomatosis
Paola Fugazzola, Federico Coccolini, Giulia Montori, Marco Ceresoli, Paolo Baggi, Antonio Costanzo, Matteo Tomasoni, Francesco Gregis, Silvia Nozza, Luca Ansaloni
Effect of Helicobacter pylori infection on outcomes in resected gastric and gastroesophageal junction cancer
Jennifer M. Kolb, Umut Ozbek, Noam Harpaz, Randall F. Holcombe, Celina Ang
Sarcopenia related to neoadjuvant chemotherapy and perioperative outcomes in resected gastric cancer: a multi-institutional analysis
Katelin A. Mirkin, Franklyn E. Luke, Alexandra Gangi, Jose M. Pimiento, Daniel Jeong, Christopher S. Hollenbeak, Joyce Wong

Educational Case Series of the Memorial Sloan Kettering Cancer Center

An elderly man with remote history of metastatic melanoma now with localized pancreas cancer and new liver masses
Neil Vasan, Maria Ignez Braghiroli, Alexander N. Shoushtari, Richard Kinh Gian Do, Marcia Edelweiss, Ali Shamseddine, Walid Faraj, Deborah Mukherji, Ali Haydar, Ashwaq Olayan, Fouad Sabatin, Rita Assi, Imane El Dika, Leonard B. Saltz, Ghassan K. Abou-Alfa, Eileen M. O’Reilly